Anatomic hepatic resection is considered now a "gold standard" in the treatment of patients, suffering metastatic colorectal cancer (CRR) because it secures 23-35% survival solely and 35-58% in combination with chemotherapy. The immediate results of cornbined treatment and its impact on survival of patients, suffering CRR with hepatic metastases, were studied up. In Lvivskiy Oncological Centre and Zaporizhskiy Oncological Dispensary in 2000-2009 yrs there was conducted combined treatment of 60 patients, suffering metastatic CRR. Combined treatment consisted of the large bowel tumor extirpation, hepatic resection and adjuvant chemotherapy (ACT). Median of overall survival in patients after combined treatment conduction had constituted 24.1 mo. The trustworthy improvement of late follow-up results was stimulated by combined application of hepatic resection with ACT. Small rate of complications and low postoperative lethality were noted.

Download full-text PDF

Source

Publication Analysis

Top Keywords

treatment patients
12
hepatic resection
12
patients suffering
12
combined treatment
12
metastatic colorectal
8
suffering metastatic
8
survival patients
8
treatment
6
combined
5
patients
5

Similar Publications

Background: Radioactive iodine (RAI) is a common treatment for various thyroid diseases. Previous studies have suggested susceptibility of parathyroid glands to the mutagenic effect of RAI and the development of primary hyperparathyroidism (PHPT). We tested the possible link between prior RAI treatment, disease presentation, and treatment outcomes.

View Article and Find Full Text PDF

Introduction: Solitary plasmacytomas are tumors characterized by a local increase of malignant plasma cells in soft tissue or bone and may occur anywhere without evidence of systemic disease. The aim was to focus on the main surgical techniques and outcomes for this rare chest wall tumor.

Methods: Patients with solitary plasmacytoma involving a rib, who were operated for diagnostic or treatment purposes between 2018 and 2023 were retrospectively reviewed.

View Article and Find Full Text PDF

Importance: Endocrine treatments, such as Tamoxifen (TAM) and/or Aromatase inhibitors (AI), are the adjuvant therapy of choice for hormone-receptor positive breast cancer. These agents are associated with menopausal symptoms, adversely affecting drug compliance. Topical estrogen (TE) has been proposed for symptom management, given its' local application and presumed reduced bioavailability, however its oncological safety remains uncertain.

View Article and Find Full Text PDF

Tumour-infiltrating Lymphocytes and Radiation Therapy in Rectal Cancer: Systematic Review and Meta-analysis.

Clin Oncol (R Coll Radiol)

December 2024

Faculty of Medicine and Health Sciences, University of Antwerp, Prinsstraat 13, 2000, Antwerp, Belgium; Department of Radiation Oncology, Iridium Netwerk, Oosterveldlaan 22, 2610, Antwerp, Belgium. Electronic address:

Aim: Tumour-infiltrating lymphocytes (TILs) represent a promising cancer biomarker. Different TILs, including CD8+, CD4+, CD3+, and FOXP3+, have been associated with clinical outcomes. However, data are lacking regarding the value of TILs for patients receiving radiation therapy (RT).

View Article and Find Full Text PDF

Rationale: Gastric antral vascular ectasia (GAVE) is a rare acquired lesion characterized by vascular dilation in the gastric antrum, frequently results in occult or overt gastrointestinal bleeding. Endoscopic intervention remains the cornerstone of therapy. Argon plasma coagulation was previously considered a first treatment option.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!